Interview with Alex Zhavoronkov, CEO of Insilico Medicine – Speaker at PMWC 2018 Silicon Valley
Q: Everyone is talking about the China’s big push into AI. What is happening in China?...
Q: Everyone is talking about the China’s big push into AI. What is happening in China?...
Q: Can you describe some of the initial challenges you faced in understanding how the CRISPR system works?...
Q: Can you share some of the latest discoveries in new drugs and diagnostics that scientists at the Helen Diller Family Comprehensive Cancer Center are working on?...
Q: What challenges are there when it comes to defining the commercialization strategy for when marrying a drug with a diagnostics?...
Q: What impact will a pay-for-performance model have on healthcare, the patient and physician, the pharmaceutical industry, or the health insurance provider?...
We had a chance to sit down with Dr. Simon Kos, CMO, Microsoft who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January....
We had a chance to sit down with Dr. Slava Akmaev - who will be speaking at our upcoming PMWC 2018 Silicon Valley conference this coming January - to discuss his vision of "why data-driven research is important, and how machine learning and AI will advance...
Q: iSpecimen recently announced the launch of the iSpecimen Marketplace for human biospecimens. Can you tell us more about this marketplace? Q: How do you ensure the protection of patient/donor privacy and compliance with regulations that govern the use of healthcare data and biospecimens for...
We had a chance to sit down with Dr. Elizabeth Blackburn to discuss telomeres and telomerase and their impact on the human lifespan. To learn more about the different AI and machine learning sessions planned for PMWC 2018 SV, see the full agenda here. Q: Your research...
Kim, you are the chair of Solid Tumor Oncology and Investigational Therapeutics and the Donald S. Kim distinguished chair for cancer research at the Levine Cancer Institute, Carolinas HealthCare System in Charlotte, NC. Q: What are some of the activities of the Levine Cancer Institute to address...